Managers
British Patient Capital has made a EUR25 million commitment to the Nauta Tech Invest V Fund, as Nauta Capital announces its final close at EUR190 million.
Investing from late seed and Series A, the fund has already invested in 11 companies in verticals including Fintech, Insurtech, Retailtech, and Open Source, among others.
Nauta Capital specialises in capital-efficient early-stage B2B software companies. The firm’s main areas of interest include SaaS solutions with strong network effects, vertically focused enterprise tech with the potential to transform large industries as well as those leveraging deeptech applications to solve challenges faced by large enterprises.
Aura Biosciences, a portfolio company of Spanish biotechnology venture capital firm Ysios Capital, has priced its initial public offering (IPO) and is trading on the Nasdaq Global Market (NASDAQ: AURA).
Global investment firm Carlyle has acquired a majority stake in CSS AG (CSS), a German business software provider with a focus on accounting, controlling and human resources (HR) software. Majority shareholder Michael Friemel will retain a large minority stake in CSS and will continue to lead the company as CEO.
Founded in 1984, CSS is headquartered in Künzell, Germany, and serves and supports its customers from eight additional regional offices. CSS is the only vendor with a fully integrated all-in-one business solution, named eGECKO, for accounting, controlling and HR modules which is specifically targeted at the needs of local and
BC Partners is to acquire a controlling stake in Pet City, pet retailer in Greece. Specific terms of the transaction have not been disclosed.
The deal represents the first investment of BC Partners GR Investment LP (BCPGR), a special purpose fund which seeks to invest in and support high-growth small and medium-sized companies in Greece. This transaction and BCPGR is a testament to BC Partners’ unique deep regional network across Europe.
Pet City was founded in 1988 and has grown as a family-owned business to be the clear market leader in Greece serving around 3 million customers. The founding
Sir Paul Marshall has today announced a GBP50 million donation to the London School of Economics’ (LSE) Marshall Institute, which will kick-start a unique accelerator for social impact ventures, as part of his long-term ambition to create a philanthropic cooperative that brings together capital, expertise and passion for change in one place.
The Marshall Impact Accelerator will provide a brand new platform for the world’s most promising social ventures, scaling them to help us tackle global challenges in areas such as health, the environment, social inequality, public policy and developmental economics.
Bringing together LSE’s world-leading research expertise and the Marshall
iCapital Network has added to its private investments offering with the launch of the AMG Pantheon Fund, LLC, BlackRock Private Investments Fund, Carlyle Tactical Private Credit Fund, and Hamilton Lane Private Assets Fund on its platform.
The expansion of iCapital’s fund offerings suitable for accredited investors and qualified clients enables financial advisors and their clients to access the return and diversification potential offered by private market investments with accessible investment minimums and simplified operations.
During the past 12 months, iCapital has prioritised expanding the selection of registered funds and other vehicles for accredited investors available on its flagship platform. These
Yieldstreet, a multi-asset alternative investment platform providing access to alternatives for millions of people, has launched the first pre-term liquidity event on a private market investment and fulfilled a key objective from its recent Series C fundraising announcement.
This feat is an extension of new technology built to offer liquidity via a digital tender offer to shareholders of the Yieldstreet Prism Fund, a ‘40 Act Fund, reducing friction to an archaic process. To date, the Prism Fund has conducted quarterly tender offers beginning in the second quarter of this year and expects to continue to conduct them on a quarterly
Vestwell, a fintech engine powering leading workplace savings programmes, is to acquire Sumday, a subsidiary of The Bank of New York Mellon Corporation (BNY Mellon) managing and administers 529 college savings, 529A ABLE, and Secure Choice/Auto-IRA state-sponsored savings programs.
The terms of the deal have not been disclosed.
BNY Mellon will act as the preferred servicing agent for the state programs managed by Vestwell, providing custody, fund accounting, record-keeping services, and where applicable, sub-advisory services through its affiliate Lockwood Advisors, Inc. (an investment adviser registered in the US under the Investment Advisers Act of 1940). Vestwell will continue to play
TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, has completed a significant investment in Keter Environmental Services (Keter), a full-service recycling and waste management company focused on providing first-class sustainable recycling and waste programs.
Financial terms of the transaction have not been disclosed.
Over the past two decades, Keter has grown into a provider of outsourced full-service recycling and waste management services in the United States. Through its high-quality and tech-enabled offerings, the company now helps more than 500 locations across 46 states manage their waste more efficiently and sustainably.
“Partnering with TPG will
ShangBay Capital, a venture capital firm focused on investing in early-stage healthcare companies, has appointed Robert Kamen PhD as a Senior Advisor.
ShangBay Capital’s team has a proven track record of identifying, financing, and building various healthcare companies over the last several years. The team brings deep operational experience from more than 100 years of combined industry experience to help entrepreneurs build lasting companies.
“Bob will bring significant value from his more than 35 years of experience of launching and operating successful biotech and pharmaceutical companies,” says William Dai, Founding Managing Partner. “His in-depth experience will help ShangBay continue to
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm